Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.16 BRL | -2.36% | -4.37% | -3.96% |
05-08 | Transcript : Odontoprev S.A., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Odontoprev S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 2.32B 442M 34.64B | Sales 2025 * | 2.45B 468M 36.72B | Capitalization | 6.15B 1.17B 91.95B |
---|---|---|---|---|---|
Net income 2024 * | 519M 98.99M 7.77B | Net income 2025 * | 542M 103M 8.11B | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | 551M 105M 8.24B | Net cash position 2025 * | 597M 114M 8.94B | EV / Sales 2025 * | 2.26 x |
P/E ratio 2024 * |
11.8
x | P/E ratio 2025 * |
11.5
x | Employees | 1,947 |
Yield 2024 * |
7.71% | Yield 2025 * |
7.73% | Free-Float | 47.11% |
Latest transcript on Odontoprev S.A.
1 day | -2.36% | ||
1 week | -4.37% | ||
1 month | -7.00% | ||
3 months | -10.79% | ||
6 months | -0.18% | ||
Current year | -3.96% |
Managers | Title | Age | Since |
---|---|---|---|
Rodrigo Bacellar
CEO | Chief Executive Officer | 57 | 31/05/16 |
Director of Finance/CFO | - | 31/12/05 | |
Rose Gabay
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 02/05/19 | |
Director/Board Member | 78 | 31/12/06 | |
Director/Board Member | 76 | 31/03/08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 2 M€ | -14.14% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.61% | - | |
0.00% | 34 M€ | +3.86% | - | |
0.00% | 34 M€ | +7.50% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 11.16 | -2.36% | 1,009,400 |
29/05/24 | 11.43 | +0.62% | 1,119,400 |
28/05/24 | 11.36 | -0.61% | 1,192,000 |
27/05/24 | 11.43 | -2.06% | 789,400 |
Delayed Quote Sao Paulo, May 31, 2024 at 09:07 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.96% | 1.17B | |
-10.34% | 5.7B |
- Stock Market
- Equities
- ODPV3 Stock